With Nestle, we have developed a product specifically to support the patients who are on this therapy, called Celevida GLP+, which we will launch in April, MV Ramana, Dr Reddys CEO of branded markets, India, told reporters on Saturday
How will this affect my long-term health
Celebrities are doing it
GSTT1 (null) and GSTP1 (AB/BB) are additional polymorphisms related to a reduction in GST activity
This can result in inconsistent dosing and make patients have symptoms of an underactive or overactive thyroid
[1] Dose-escalation studies, such as a 12-week trial on gradual titration, revealed that beginning at lower doses (e.g., 4 mg) and slowly increasing to therapeutic levels significantly reduced the incidence of nausea, vomiting, and diarrhoea